Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measures

被引:266
作者
Gamelin, E
Gamelin, L
Bossi, L
Quasthoff, S
机构
[1] Ctr Paul Papin, F-49033 Angers, France
[2] Karl Franzens Univ Graz, Dept Neurol, Graz, Austria
关键词
D O I
10.1053/sonc.2002.35525
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:21 / 33
页数:13
相关论文
共 71 条
  • [1] The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons
    Adelsberger, H
    Quasthoff, S
    Grosskreutz, J
    Lepier, A
    Eckel, F
    Lersch, C
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 406 (01) : 25 - 32
  • [2] Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen
    André, T
    Bensmaine, MA
    Louvet, C
    François, E
    Lucas, V
    Desseigne, F
    Beerblock, K
    Bouché, O
    Carola, E
    Merrouche, Y
    Morvan, F
    Dupon-André, G
    de Gramont, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) : 3560 - 3568
  • [3] Calcium block of Na+ channels and its effect on closing rate
    Armstrong, CM
    Cota, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) : 4154 - 4157
  • [4] Ion channel mutations and diseases of skeletal muscle
    Barchi, RL
    [J]. NEUROBIOLOGY OF DISEASE, 1997, 4 (3-4) : 254 - 264
  • [5] The use of anticonvulsants in neurological conditions other than epilepsy - A review of the evidence from randomised controlled trials
    Beghi, E
    [J]. CNS DRUGS, 1999, 11 (01) : 61 - 82
  • [6] Boughattas N., 1994, Proceedings of the American Association for Cancer Research Annual Meeting, V35, P433
  • [7] EPISODIC ATAXIA MYOKYMIA SYNDROME IS ASSOCIATED WITH POINT MUTATIONS IN THE HUMAN POTASSIUM CHANNEL GENE, KCNA1
    BROWNE, DL
    GANCHER, ST
    NUTT, JG
    BRUNT, ERP
    SMITH, EA
    KRAMER, P
    LITT, M
    [J]. NATURE GENETICS, 1994, 8 (02) : 136 - 140
  • [8] CARBOPLATIN - THE CLINICAL SPECTRUM TO DATE
    CANETTA, R
    ROZENCWEIG, M
    CARTER, SK
    [J]. CANCER TREATMENT REVIEWS, 1985, 12 : 125 - 136
  • [9] Cavaletti G, 2000, CLIN CANCER RES, V6, p4537S
  • [10] Cavaletti G, 1998, ANTICANCER RES, V18, P3797